Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 235

1.

Use of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis.

Mahler SA, Stopyra JP, Apple FS, Riley RF, Russell GB, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Herrington DM, Burke GL, Miller CD.

Clin Biochem. 2017 Jan 10. pii: S0009-9120(16)30661-0. doi: 10.1016/j.clinbiochem.2017.01.003. [Epub ahead of print]

PMID:
28087371
2.

The function of cathepsins B, D, and X in atherosclerosis.

Zhao CF, Herrington DM.

Am J Cardiovasc Dis. 2016 Nov 30;6(4):163-170. eCollection 2016.

3.

Comparing Arterial Function Parameters for the Prediction of Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA).

Hom EK, Duprez DA, Jacobs DR Jr, Bluemke DA, Brumback LC, Polak JF, Peralta CA, Greenland P, Magzamen SL, Lima JA, Redheuil A, Herrington DM, Stein JH, Vaidya D, Ouyang P, Kaufman JD.

Am J Epidemiol. 2016 Dec 15;184(12):894-901. Epub 2016 Dec 6.

PMID:
27923782
4.

Associations between a Genetic Risk Score for Clinical CAD and Early Stage Lesions in the Coronary Artery and the Aorta.

Salfati EL, Herrington DM, Assimes TL.

PLoS One. 2016 Nov 18;11(11):e0166994. doi: 10.1371/journal.pone.0166994. eCollection 2016.

5.

High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).

Dawood FZ, Judd S, Howard VJ, Limdi NA, Meschia JF, Cushman M, Howard G, Herrington DM, Soliman EZ.

Am J Cardiol. 2016 Dec 15;118(12):1826-1830. doi: 10.1016/j.amjcard.2016.08.069. Epub 2016 Sep 14.

PMID:
27712649
6.

The association of calcium supplementation and incident cardiovascular events in the Multi-ethnic Study of Atherosclerosis (MESA).

Raffield LM, Agarwal S, Hsu FC, de Boer IH, Ix JH, Siscovick D, Szklo M, Burke GL, Frazier-Wood AC, Herrington DM.

Nutr Metab Cardiovasc Dis. 2016 Oct;26(10):899-907. doi: 10.1016/j.numecd.2016.07.007. Epub 2016 Jul 16.

PMID:
27514606
7.

Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.

Oseni AO, Qureshi WT, Almahmoud MF, Bertoni AG, Bluemke DA, Hundley WG, Lima JA, Herrington DM, Soliman EZ.

Heart. 2017 Jan 1;103(1):49-54. doi: 10.1136/heartjnl-2016-309516. Epub 2016 Aug 2.

PMID:
27486144
8.

Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Qureshi WT, Michos ED, Flueckiger P, Blaha M, Sandfort V, Herrington DM, Burke G, Yeboah J.

Am J Cardiol. 2016 Sep 1;118(5):691-6. doi: 10.1016/j.amjcard.2016.06.015. Epub 2016 Jun 15.

PMID:
27445216
9.

Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.

Fox ER, Samdarshi TE, Musani SK, Pencina MJ, Sung JH, Bertoni AG, Xanthakis V, Balfour PC Jr, Shreenivas SS, Covington C, Liebson PR, Sarpong DF, Butler KR, Mosley TH, Rosamond WD, Folsom AR, Herrington DM, Vasan RS, Taylor HA.

JAMA Cardiol. 2016 Apr 1;1(1):15-25. doi: 10.1001/jamacardio.2015.0300.

10.

Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis.

Yeboah J, Rodriguez CJ, Qureshi W, Liu S, Carr JJ, Lima JA, Hundley WG, Herrington DM.

J Card Fail. 2016 Oct;22(10):763-8. doi: 10.1016/j.cardfail.2016.03.013. Epub 2016 Mar 30.

PMID:
27038640
11.

C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure.

Li T, Cheng HJ, Ohte N, Hasegawa H, Morimoto A, Herrington DM, Little WC, Li W, Cheng CP.

J Pharmacol Exp Ther. 2016 Jun;357(3):545-53. doi: 10.1124/jpet.115.231696. Epub 2016 Mar 29.

PMID:
27026682
12.

HEART Pathway Accelerated Diagnostic Protocol Implementation: Prospective Pre-Post Interrupted Time Series Design and Methods.

Mahler SA, Burke GL, Duncan PW, Case LD, Herrington DM, Riley RF, Wells BJ, Hiestand BC, Miller CD.

JMIR Res Protoc. 2016 Jan 22;5(1):e10. doi: 10.2196/resprot.4802.

13.

Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.

Yeboah J, Young R, McClelland RL, Delaney JC, Polonsky TS, Dawood FZ, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM.

J Am Coll Cardiol. 2016 Jan 19;67(2):139-47. doi: 10.1016/j.jacc.2015.10.058.

14.

Mathematical modelling of transcriptional heterogeneity identifies novel markers and subpopulations in complex tissues.

Wang N, Hoffman EP, Chen L, Chen L, Zhang Z, Liu C, Yu G, Herrington DM, Clarke R, Wang Y.

Sci Rep. 2016 Jan 7;6:18909. doi: 10.1038/srep18909.

15.

Adherence to an Accelerated Diagnostic Protocol for Chest Pain: Secondary Analysis of the HEART Pathway Randomized Trial.

Mahler SA, Riley RF, Russell GB, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Bringolf J, Elliott SB, Herrington DM, Burke GL, Miller CD.

Acad Emerg Med. 2016 Jan;23(1):70-7. doi: 10.1111/acem.12835. Epub 2015 Dec 31.

16.

Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-Course.

Salfati E, Nandkeolyar S, Fortmann SP, Sidney S, Hlatky MA, Quertermous T, Go AS, Iribarren C, Herrington DM, Goldstein BA, Assimes TL.

Circ Cardiovasc Genet. 2015 Dec;8(6):803-11. doi: 10.1161/CIRCGENETICS.114.001071. Epub 2015 Sep 28.

17.

DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis.

Reynolds LM, Wan M, Ding J, Taylor JR, Lohman K, Su D, Bennett BD, Porter DK, Gimple R, Pittman GS, Wang X, Howard TD, Siscovick D, Psaty BM, Shea S, Burke GL, Jacobs DR Jr, Rich SS, Hixson JE, Stein JH, Stunnenberg H, Barr RG, Kaufman JD, Post WS, Hoeschele I, Herrington DM, Bell DA, Liu Y.

Circ Cardiovasc Genet. 2015 Oct;8(5):707-16. doi: 10.1161/CIRCGENETICS.115.001097. Epub 2015 Aug 25.

18.

Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.

Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM.

Circulation. 2015 Sep 8;132(10):916-22. doi: 10.1161/CIRCULATIONAHA.115.016846. Epub 2015 Jul 29.

19.

Microvasculature and incident atrioventricular conduction abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA).

Chacko BG, Edwards MS, Sharrett AR, Qureshi WT, Klein BE, Klein R, Herrington DM, Soliman EZ.

Vasc Med. 2015 Oct;20(5):417-23. doi: 10.1177/1358863X15586475. Epub 2015 May 21.

PMID:
25999364
20.

Association of the Lipoprotein Receptor SCARB1 Common Missense Variant rs4238001 with Incident Coronary Heart Disease.

Manichaikul A, Wang XQ, Musani SK, Herrington DM, Post WS, Wilson JG, Rich SS, Rodriguez A.

PLoS One. 2015 May 20;10(5):e0125497. doi: 10.1371/journal.pone.0125497. eCollection 2015.

Supplemental Content

Loading ...
Support Center